A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507637-19-00

Acronym

M24-291

Enrollment

Registered

2024-08-23

Start date

2024-10-15

Completion date

Unknown

Last updated

2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026